# FDA Inspection 1001337 - Central Jersey Blood Center - January 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/central-jersey-blood-center/f52fd002-917b-439e-bfb6-dbe3d7263321
Source feed: FDA_Inspections

> FDA Inspection 1001337 for Central Jersey Blood Center on January 27, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1001337
- Company Name: Central Jersey Blood Center
- Inspection Date: 2017-01-27
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 904974 - 2014-10-23](https://www.keypedia.com/records/fda_inspections/central-jersey-blood-center/08300978-95ce-4b33-9995-f049591b02bb)
- [FDA Inspection 822470 - 2013-03-01](https://www.keypedia.com/records/fda_inspections/central-jersey-blood-center/d3c25a8e-1648-4b70-9c88-91e47046ff2d)
- [FDA Inspection 728814 - 2011-06-09](https://www.keypedia.com/records/fda_inspections/central-jersey-blood-center/8eb04cc3-8cce-4801-89fb-62ba390b0808)
- [FDA Inspection 592280 - 2009-06-12](https://www.keypedia.com/records/fda_inspections/central-jersey-blood-center/63b9b08e-c4e7-479d-9581-162f9c4ad967)

Company: https://www.keypedia.com/companies/central-jersey-blood-center/6b813a54-e954-4ba2-9ff9-abce11fcf9d9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d